Alignment Healthcare, Inc.

For the period ended Dec 31, 2025. Filed Feb 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 27, 2026

ALHC$7.27-1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Alignment Healthcare, Inc.
Date: February 27, 2026	By:	/s/ John Kao
		John Kao
		Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

John Kao
Signature	Title	Date
/s/ John Kao	Chief Executive Officer (Principal Executive Officer)	February 27, 2026
/s/ James M. Head	Chief Financial Officer (Principal Financial Officer)	February 27, 2026
James M. Head
/s/ Joseph Konowiecki	Chairman of the Board	February 27, 2026
Joseph Konowiecki
/s/ Jody Bilney	Director	February 27, 2026
Jody Bilney
/s/ David Hodgson	Director	February 27, 2026
David Hodgson
/s/ Yon Jorden	Director	February 27, 2026
Yon Jorden
/s/ Jacqueline Kosecoff	Director	February 27, 2026
Jacqueline Kosecoff
/s/ Margaret McCarthy	Director	February 27, 2026
Margaret McCarthy
/s/ Mark McClellan	Director	February 27, 2026
Mark McClellan
/s/ Robbert Vorhoff	Director	February 27, 2026
Robbert Vorhoff

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.